Skip to main content

Table 7 Comparisons of HRV measurement in the group of patients with and without LVH

From: Heart rate variability and target organ damage in hypertensive patients

 

Patients with LVH

Patients without LVH

P values

 

Mean

St. Dev.

Quartiles

Mean

St. Dev.

Quartiles

 
   

1st

2nd

3rd

  

1st

2nd

3rd

 

AVNN

846.9

121.8

772.6

829.5

916.8

883.1

129.2

789.9

863.7

963.8

0.071

SDNN

123.5

37.0

101.5

118.3

142.3

118.4

36.0

91.8

112.7

142.4

0.247

SDANN

111.2

37.6

88.0

106.7

128.7

105.9

36.3

79.4

99.0

129.5

0.304

SDNN IDX

51.9

15.0

42.7

49.5

60.8

49.5

15.2

38.5

47.8

58.4

0.127

RMSSD

32.8

14.5

22.9

29.2

36.4

36.4

18.1

23.1

32.4

42.3

0.123

pNN50

9.9

10.3

3.2

7.1

11.9

11.2

9.4

3.4

9.2

17.0

0.163

TOTPWR

18472

12108

10873

15952

21928

17029

10776

8958

14057

22697

0.288

ULF

15018

10082

8177

12029

18491

13872

9043

7093

11412

18656

0.347

VLF

1892

1255

1074

1668

2393

1697

1206

923

1336

2086

0.105

LF

896

782

429

704

1092

744

619

369

556

912

0.072

HF

666

694

210

483

757

716

622

261

502

965

0.316

LF/HF

1.74

0.99

1.03

1.60

2.08

1.28

0.74

0.81

1.03

1.51

<0.001

  1. St. Dev. standard deviation.
  2. The p-values refer to Wilcoxon test.